Asahi Intecc USA

Asahi Intecc USA is owned by Asahi Intecc.

Asahi Intecc is one of the...

• Topix.

Asahi Intecc is a company listed under the stock ticker 7747 (JP).

Asahi Intecc has a direct presence in 2 countries.

They are in:

• Medical Equipment50%
• Biotechnology50%

View the org chart displaying its 3 main executives

Most searched biographies at Asahi Intecc USA

• Michael Luk, R&D Manager
• Jim Dinkel, Vice President, Medical Sales & Marketing
• David Zivkovic, Vice President of Sales

Create your alert
to follow the executive moves at Asahi Intecc USA.

Asahi Intecc has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Asahi Intecc USA

Social media about Asahi Intecc USA

• Asahi Intecc USA on Wikipedia, Google News & Yahoo Finance
• Asahi Intecc USA on LinkedIn, Twitter & YouTube

Contact by email its executives including David Zivkovic

Call Asahi Intecc USA at +1 855...

View the org chart

Register to receive your alert

Report an error